Abstract
Gastroparesis is an incompletely understood disorder characterized by vomiting, nausea, abdominal pain, and related symptoms amongst evidence of delayed gastric emptying often refractory to medical therapy. Gastric electrical stimulation (GES), using higher than physiologic frequency and low energy, has been shown to be effective in many patients with refractory symptoms and received Humanitarian Use Device approval in 2000. A meta-analysis suggests GES is effective for symptom control and favorable in gastric emptying, nutritional status, and quality of life analysis. Recent work with endoscopically placed, temporary GES indicates trial stimulation is important in the evaluation of stimulation devices. In addition, approximately 50 % of patients responded to standard settings [4, Neurogastroenterol Motil 18(4):334–338, 2006] while other patients require higher energy settings for optimal response. These recent studies offer the potential for personalization of stimulation parameters in a given patient. For GES to be accepted and adopted on more widespread basis, further evaluation of individual responses to simulation must be determined and then correlated with individual histologic, electrophysiological and biochemical findings to optimally help patients. This chapter will discuss the historical development of current GES therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abell TL, Van Cutsem E, Abrahamsson H et al (2002) Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 66(4):204–212
Abell T, McCallum R, Hocking M et al (2003) Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125(2):421–428
Abell T, Johnson W, Kedar A et al (2011) A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endoscopic 74:496–503
Abidi N, Starkebaum WL, Abell TL (2006) An energy algorithm improves symptoms in some patients with gastroparesis and treated with gastric electrical stimulation. Neurogastroenterol Motil 18(4):334–338. doi:10.1111/j.1365-2982.2006.00765.x
Anand C, Al-Juburi A, Familoni B et al (2007) Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers. Digestion 75(2–3):83–89
Chen J, Xu X, Zhang J et al (2005) Efficiency and efficacy of multi-channel gastric electrical stimulation. Neurogastroenterol Motil 17:878–882
Chu H, Lin Z, Zhong L et al (2011) A meta-analysis: the treatment of high-frequency gastric electrical stimulation for gastroparesis. J Gastroenterol Hepatol. doi:10.1111/j.1440-1746.2011.06999.x
Cutts TF, Luo J, Abell TL et al (2005) Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term healthcare benefits? Neurogastroenterol Motil 17:35–43
Daram S, Abell T (2011) A brief history and future directions for permanent, temporary, and endoscopic GES. In: Parkman HP, McCallum RW (eds) Gastroparesis: pathophysiology, presentation, and treatment. Springer Science+Business Media, New York
Dieffenbach W (1911) Electric treatment of intestinal obstruction and postoperative paralysis of the bowel. J Am Med Assoc 56(13):958–959
Familoni BO, Abell TL, Nemoto D et al (1997) Efficacy of electrical stimulation at frequencies higher than basal rate in canine stomach. Dig Dis Sci 42(5):892–897
Familoni B, Abell T, Gan Z, Voeller G (2005) Driving gastric electrical activity with stimulation. Ann Biomed Eng 33(3):355–363. doi:10.1007/s10439-005-1738-6
Gastroparesis Clinical Research Consortium (2011) Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 140(1):101–115
Grover M, Farrungia G, Lurken M et al (2011) Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 140:1575–1585
Heberden W (1806) Commentaries on the history and causes of diseases, 3rd edn. Payne and Foss London, United Kingdom
Hughes JD, Griffith J, Lahr CJ et al (2011) Intraoperative electrogastrogram and longitudinal symptom scores following gastric stimulation for gastroparesis. Abstract nr 76. The international neuromodulation society 10th world congress, London, England
Janssen P, Oudenhove L, Bisschops R, Tack J (2011) Idiopathic gastroparesis or functional dyspepsia with delayed gastric emptying: where is the difference? Gastroenterology 140(7):2145–2146
Kassander P (1958) Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 48(4):797–812
Kelly KA, Code CF (1971) Canine gastric pacemaker. Am J Physiol 220(1):112–118
Mair R, Onos K, Hembrook J (2011) Cognitive activation by central thalamic stimulation: the Yerkes-Dodson law revisited. Dose Response 9(3):313–331. doi:10.2203/dose-response.10-017.Mair
McCallum R, Snape W, Brody F et al (2010) Gastric electrical stimulation with enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol 8(11):947–954.e1
O’Grady G, Egbuji JU, Du P et al (2009) High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg 33(8):1693–1701
Parkman HP, Hasler WL, Fisher RS (2004) American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127:1592–1622
Pasricha P, Colvin R, Yates K et al (2011) Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol 9:567–576
Quast D, Beall A, DeBakey M (1965) Clinical evaluation of the gastrointestinal pacer. Surg Gyn Obs 120:135–137
Soffer E, Abell T, Lin Z et al (2009) Review article: gastric electrical stimulation for gastroparesis—physiologic foundations, technical aspects and clinical implications. Aliment Pharmacol Ther 30:681–694. doi:10.1111/j.1365-2036.2009.04082.x
Tougas G, Eaker EY, Abell TL (2000) Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 95(6):1456–1462
United States Food and Drug Administration (2000) Device approvals and clearances: enterra therapy system. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=H990014. Accessed Dec 20 2011
Yin J, Chen J (2006) Inhibitory effects of gastric electrical stimulation on ghrelin-induced excitatory effects on gastric motility and food intake in dogs. Scand J Gastroenterol 41(8):903–909
Zarate N, Farmer A, Grahame R et al (2010) Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link? Neurogastroenterol Motil 22(3):252–278
Acknowledgments
The authors would like to thank Evelyn Martin, LPNII and Angela Ashley, LPN I—GES nurses. We would also like to thank the staff of the GI Division, GI Laboratory, Department of Nuclear Medicine and Department of Pathology laboratory at the University of Mississippi Medical Center for their help.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Griffith, J. et al. (2013). Gastric Electrical Stimulation: Twentieth Century Development to Twenty-First Century Implementation and Personalization of Programming. In: Cheng, L., Pullan, A., Farrugia, G. (eds) New Advances in Gastrointestinal Motility Research. Lecture Notes in Computational Vision and Biomechanics, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6561-0_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-6561-0_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6560-3
Online ISBN: 978-94-007-6561-0
eBook Packages: EngineeringEngineering (R0)